These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38212952)

  • 1. Metabolic analysis using HR-MAS in prostate tissue for prostate cancer diagnosis.
    Panach-Navarrete J; González-Marrachelli V; Morales-Tatay JM; García-Morata F; Sales-Maicas MÁ; Monleón-Salvado D; Martínez-Jabaloyas JM
    Prostate; 2024 May; 84(6):549-559. PubMed ID: 38212952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes.
    Dudka I; Lundquist K; Wikström P; Bergh A; Gröbner G
    J Transl Med; 2023 Nov; 21(1):860. PubMed ID: 38012666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
    Santos CF; Kurhanewicz J; Tabatabai ZL; Simko JP; Keshari KR; Gbegnon A; Santos RD; Federman S; Shinohara K; Carroll PR; Haqq CM; Swanson MG
    NMR Biomed; 2010 May; 23(4):391-8. PubMed ID: 20033906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy.
    Hansen AF; Høiem TS; Selnaes KM; Bofin AM; Størkersen Ø; Bertilsson H; Wright AJ; Giskeødegård GF; Bathen TF; Rye MB; Tessem MB
    NMR Biomed; 2023 May; 36(5):e4694. PubMed ID: 35032074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
    Giskeødegård GF; Bertilsson H; Selnæs KM; Wright AJ; Bathen TF; Viset T; Halgunset J; Angelsen A; Gribbestad IS; Tessem MB
    PLoS One; 2013; 8(4):e62375. PubMed ID: 23626811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies.
    Mirnezami R; Jiménez B; Li JV; Kinross JM; Veselkov K; Goldin RD; Holmes E; Nicholson JK; Darzi A
    Ann Surg; 2014 Jun; 259(6):1138-49. PubMed ID: 23860197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy.
    Chae EY; Shin HJ; Kim S; Baek HM; Yoon D; Kim S; Shim YE; Kim HH; Cha JH; Choi WJ; Lee JH; Shin JH; Lee HJ; Gong G
    PLoS One; 2016; 11(8):e0161038. PubMed ID: 27560937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.
    Dudka I; Thysell E; Lundquist K; Antti H; Iglesias-Gato D; Flores-Morales A; Bergh A; Wikström P; Gröbner G
    BMC Cancer; 2020 May; 20(1):437. PubMed ID: 32423389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection rate at second and third biopsy. Predictive factors and risk groups for cancer diagnosis.
    Castello-Porcar A; García-Morata F; Martinez-Jabaloyas JM
    Arch Esp Urol; 2014 Sep; 67(7):605-14. PubMed ID: 25241833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
    Bigliocchi M; Marini M; Nofroni I; Perugia G; Shahabadi H; Ciccariello M
    Minerva Urol Nefrol; 2007 Dec; 59(4):395-402; 403-6. PubMed ID: 17947956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.
    Haukaas TH; Moestue SA; Vettukattil R; Sitter B; Lamichhane S; Segura R; Giskeødegård GF; Bathen TF
    Front Oncol; 2016; 6():17. PubMed ID: 26858940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
    Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.
    Choi JS; Baek HM; Kim S; Kim MJ; Youk JH; Moon HJ; Kim EK; Han KH; Kim DH; Kim SI; Koo JS
    PLoS One; 2012; 7(12):e51712. PubMed ID: 23272149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
    Kumar D; Gupta A; Mandhani A; Sankhwar SN
    Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.